DXR DAXOR CORP
· Nasdaq · SEC CIK 27367 · Fiscal year ends 12/31
Financial factors as of 2011-12-31 (FY2011), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-8.4%
TTM net income YoY-244.6%
TTM EPS YoY-245.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin54.9%
Operating margin-400.1%
Net margin-496.8%
FCF margin-458.5%
EBITDA margin-380.0%
Returns
ROE-17.3%
ROA-8.1%
ROIC (approx.)-11.0%
Asset turnover0.02x
Leverage & solvency
Liabilities / assets57.8%
Debt / equity0.00x
Current ratio1.66x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.91x
Accruals ratio-0.8%
Payout ratio—
Capex / revenue8.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2011Q4*2011-12-31 | 2011Q32011-09-30 | 2011Q22011-06-30 | 2010Q4*2010-12-31 | 2010Q32010-09-30 | 2010Q22010-06-30 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $369,830 | $340,907 | $358,139 | $361,372 | $453,281 | $368,332 |
| Cost of revenue | $176,954 | $149,376 | $160,727 | $184,720 | $185,742 | $165,411 |
| Gross profit | $192,876 | $191,531 | $197,412 | $176,652 | $267,539 | $202,921 |
| R&D expense | $709,528 | $637,051 | $669,783 | $720,376 | $694,730 | $734,569 |
| SG&A expense | $488,956 | $815,552 | $871,426 | $983,296 | $857,674 | $973,422 |
| Operating income | -$1.01M | -$1.26M | -$1.34M | -$1.53M | -$1.28M | -$1.51M |
| Interest expense | — | $29,769 | $81,260 | — | $20,323 | $8,919 |
| Income tax | -$1.05M | -$2.85M | -$182,331 | $1.04M | $1.80M | -$39,946 |
| Net income | -$1.49M | -$4.18M | -$184,520 | $2.27M | $2.60M | $188,356 |
| EBITDA | -$934,325 | -$1.19M | — | -$1.45M | -$1.21M | — |
| EPS (basic) | — | -0.99 | -0.04 | — | 0.62 | 0.04 |
| EPS (diluted) | — | -0.99 | -0.04 | — | 0.62 | 0.04 |
| Dividends declared per share | 0.10 | 0.00 | 0.15 | 0.65 | 0.25 | 0.10 |
| Balance sheet | ||||||
| Cash & equivalents | $59,625 | $29,711 | $111,769 | $57,741 | $107,043 | $213,402 |
| Receivables | $219,684 | $189,612 | $193,473 | $178,820 | — | — |
| Inventory | $301,534 | $313,494 | $357,334 | $363,634 | — | — |
| Current assets | $81.69M | $84.15M | $92.12M | $86.99M | — | — |
| PP&E, net | $4.00M | $4.07M | $4.08M | $4.17M | — | — |
| Total assets | $85.72M | $88.25M | $96.24M | $91.20M | — | — |
| Current liabilities | $49.26M | $50.37M | $50.38M | $43.90M | — | — |
| Total liabilities | $49.51M | $50.63M | $50.66M | $44.20M | — | — |
| Shareholders' equity | $36.22M | $37.62M | $45.58M | $47.00M | — | — |
| Shares outstanding | 4.20M | 4.22M | 4.22M | 4.23M | — | — |
| Cash flow statement | ||||||
| Operating cash flow | -$989,909 | -$613,236 | — | -$1.84M | -$1.22M | — |
| Capital expenditure | $4,700 | $58,208 | — | $35,007 | $90,626 | — |
| Free cash flow | -$994,609 | -$671,444 | — | -$1.87M | -$1.31M | — |
| Investing cash flow | -$8.05M | -$3.28M | — | $6.45M | -$108,947 | — |
| Financing cash flow | $9.07M | $3.81M | — | -$4.67M | $1.23M | — |
| Depreciation & amortization | $71,283 | $72,479 | — | $73,817 | $73,935 | — |
| Stock-based compensation | $3,892 | $3,893 | — | — | — | — |
| Dividends paid | $420,531 | $0 | — | $2.75M | $1.06M | — |
| Share buybacks | — | $107 | — | — | — | — |
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.